HIA
WST icon

HFM Investment Advisors’s West Pharmaceutical WST Stock Holding History

HFM Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
8
+5
+167% +$1.53K ﹤0.01% 320
2026
Q1 		$752 Buy
3
+1
+50% +$249 ﹤0.01% 517
2025
Q4 		$551 Hold
2
– – ﹤0.01% 685
2025
Q3 		$525 Buy
2
+1
+100% +$243 ﹤0.01% 635
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 956

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

HFM Investment Advisors's WST Position: Q2 2026 in Review

HFM Investment Advisors increased its West Pharmaceutical (WST) stake by 167% in Q2 2026, buying an estimated $1.53K and bringing the position to 8 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #320.

HFM Investment Advisors first reported a position in WST in Q2 2025 and has held it in 5 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • HFM Investment Advisors held 8 shares of West Pharmaceutical worth $2.87K as of Q2 2026.
  • HFM Investment Advisors bought 5 West Pharmaceutical shares in Q2 2026, an estimated $1.53K.
  • West Pharmaceutical made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #320 holding.
  • HFM Investment Advisors first reported a position in West Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.